Recruiting Heart Attack Studies in Maitland
A Dose-finding Trial With Lu-AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments
The purpose of this trial is to determine which doses of Lu AG09222 are recommended to help prevent migraines. People who join this trial have already tried 1 to 4 other available medications to preve...
[18F]PI-2620 Phase 3 Histopathological Study
This study is an open-label, multi-center, non-randomized pivotal Phase 3 study to assess the efficacy and safety of PET imaging with \[18F\]PI-2620 for detection of tau deposition in subjects with Al...
About Heart Attack Clinical Trials in Maitland
A heart attack (myocardial infarction) occurs when blood flow to part of the heart muscle is blocked, usually by a blood clot. It is a medical emergency requiring immediate treatment. Long-term management includes medications, lifestyle changes, and cardiac rehabilitation.
There are currently 2 heart attack clinical trials recruiting participants in Maitland, FL. These studies are seeking a combined 1,045 participants. Research is being sponsored by H. Lundbeck A/S, Life Molecular Imaging Ltd. Clinical trial participation is free and participants receive study-related medical care at no cost.
Heart Attack Clinical Trials in Maitland — FAQ
Are there heart attack clinical trials in Maitland?
Yes, there are 2 heart attack clinical trials currently recruiting in Maitland, FL. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Maitland?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Maitland research site will contact you about next steps.
Are clinical trials in Maitland free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Maitland studies also compensate for your time and travel.
What heart attack treatments are being tested?
The 2 active trials in Maitland are testing new therapies including novel drugs, biologics, and treatment approaches for heart attack.
Data updated March 2, 2026 from ClinicalTrials.gov